BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36983713)

  • 21. Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology.
    Birner P; Schindl M; Stani J; Oberhuber G; Czerwenka K; Vutuc C; Breitenecker G
    Wien Klin Wochenschr; 2000 Sep; 112(17):761-6. PubMed ID: 11042905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
    Gao D; Zhang Y; Zhu M; Liu S; Wang X
    PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
    Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
    Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
    Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
    Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening.
    Cang W; Li Q; Gu L; Hong Z; Hu Y; Di W; Qiu L
    Cancer Prev Res (Phila); 2021 Mar; 14(3):355-362. PubMed ID: 33229338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk Human Papillomavirus Determination in Formalin-fixed, Paraffin-embedded Cervical Tissue Using the Roche Cobas 4800 System: A Comparative Study With Liquid-based Cytology.
    Tardío JC; Cambero O; Sánchez-Estévez C; Sánchez-García AB; Angulo F; Moreno A
    Int J Gynecol Pathol; 2019 Jan; 38(1):11-16. PubMed ID: 29140880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
    Hariri S; Steinau M; Rinas A; Gargano JW; Ludema C; Unger ER; Carter AL; Grant KL; Bamberg M; McDermott JE; Markowitz LE; Brewer NT; Smith JS
    PLoS One; 2012; 7(3):e34044. PubMed ID: 22479516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of precancerous cervical lesions in iran: a cost minimizing study.
    Nahvijou A; Sari AA; Zendehdel K; Marnani AB
    Asian Pac J Cancer Prev; 2014; 15(19):8209-13. PubMed ID: 25339007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical correlation of cervical cancer screening using Pap smear test.
    Sharif YH
    J Popul Ther Clin Pharmacol; 2022; 29(1):e1-e8. PubMed ID: 35686892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden and Associated Genotype Patterns of High-Risk Human Papilloma Virus Infection and Cervical Cytology Abnormalities among Women in Central India.
    Gupta S; Purwar S; Gupta P; Halder A; Gupta A; Pushpalatha K; John JH
    Infect Dis Obstet Gynecol; 2022; 2022():3932110. PubMed ID: 35634175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.
    Castro FA; Koshiol J; Quint W; Wheeler CM; Gillison ML; Vaughan LM; Kleter B; van Doorn LJ; Chaturvedi AK; Hildesheim A; Schiffman M; Wang SS; Zuna RE; Walker JL; Dunn ST; Wentzensen N
    BMC Infect Dis; 2015 Nov; 15():544. PubMed ID: 26607224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and type-distribution of human papillomavirus from paraffin-embedded blocks of high grade cervical intraepithelial neoplasia lesions in Thailand.
    Swangvaree SS; Kongkaew P; Ngamkham J
    Asian Pac J Cancer Prev; 2013; 14(2):1023-6. PubMed ID: 23621179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROLE OF MICRORNA-155 AS A DIAGNOSTIC BIOMARKER FOR HUMAN PAPILLOMAVIRUS ASSOCIATED CERVICAL CANCER.
    Jihad NA; Issa YW
    Wiad Lek; 2021; 74(9 cz 2):2301-2304. PubMed ID: 34824176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.